Related Experiment Videos
Alpha-fetoprotein levels in amniotic fluid between 11 and 15 weeks
B F Crandall1, F W Hanson, F Tennant
1Department of Psychiatry, University of California, Los Angeles.
American Journal of Obstetrics and Gynecology
|May 1, 1989
Summary
Alpha-fetoprotein (AFP) levels in amniotic fluid peak early in pregnancy and decline weekly. Accurate monitoring of AFP is crucial for reliable early prenatal diagnosis, preventing errors from extrapolated data.
Area of Science:
- Biochemistry
- Prenatal Diagnostics
- Maternal-Fetal Medicine
Background:
- Alpha-fetoprotein (AFP) is a key biomarker in prenatal screening.
- Accurate gestational dating is essential for interpreting AFP levels.
- Previous methods may have used extrapolated data, leading to potential inaccuracies.
Purpose of the Study:
- To establish the precise pattern of amniotic fluid AFP levels during early gestation.
- To highlight the risks of using extrapolated cutoff values for AFP.
- To emphasize the importance of accurate AFP monitoring for prenatal diagnosis.
Main Methods:
- Analysis of amniotic fluid samples collected weekly.
- Quantification of alpha-fetoprotein concentrations.
- Comparison of observed AFP trends with extrapolated values.
Main Results:
- Amniotic fluid AFP levels peak at approximately 13 weeks of gestation.
- AFP levels demonstrate a consistent decline of about 10% per week until 20 weeks.
- Extrapolation of later gestational data results in artificially high AFP cutoff values.
Conclusions:
- The established pattern of amniotic fluid AFP is critical for accurate prenatal screening.
- Using extrapolated cutoff levels can lead to misinterpretation and diagnostic errors.
- Precise monitoring of AFP offers a significant advantage for early and reliable prenatal diagnosis.